"Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Vellaichamy, Adaikkalam ^a,c   Dezso, Zoltán ^b   JeBailey, Lellean ^b   Chinnaiyan, Arul M ^a   Sreekumar, Arun ^a,d   Nesvizhskii, Alexey I ^a   Omenn, Gilbert S ^a   Bugrim, Andrej ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b GeneGo bioinformatics software Inc   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID SYNTHASE; FIBROBLAST GROWTH FACTOR; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; GLYCOGEN SYNTHASE KINASE 3; GROWTH FACTOR; INTERFERON REGULATORY FACTOR 1; JANUS KINASE; KALLIKREIN 3; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; N MYC DOWNSTREAM REGULATED REGULATED 1 PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C; SMAD3 PROTEIN; SMAD4 PROTEIN; SOMATOMEDIN RECEPTOR; STAT1 PROTEIN; STAT3 PROTEIN; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANDROGENS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTEOMICS;

EID: 77956194472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010936     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics. CA Cancer J Clin 59: 225-249.
2. Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, et al. (2004) Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Res 64: 8620-8629.
3. Fan W, Yanase T, Morinaga H, Okabe T, Nomura M, et al. (2007) Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of FoxO1 with androgen receptor. J Biol Chem 282: 7329-7338.
4. Oosterhoff JK, Grootegoed JA, Blok LJ (2005) Expression profiling of androgendependent and -independent LNCaP cells: EGF versus androgen signalling. Endocr Relat Cancer 12: 135-148.
5. Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N (2008) TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate 68: 287-295.
6. Zhu B, Kyprianou N (2005) Transforming growth factor beta and prostate cancer. Cancer Treat Res 126: 157-173.
7. Memarzadeh S, Xin L, Mulholland DJ, Mansukhani A, Wu H, et al. (2007) Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 12: 572-585.
8. Rosini P, Bonaccorsi L, Baldi E, Chiasserini C, Forti G (2002) Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation. Prostate 53: 310-321.
9. Boddy JL, Fox SB, Han C, Campo L, Turley H, et al. (2005) The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin Cancer Res 11: 7658-7663.
10. Sørlie T (2005) Molecular portraits of breast cancer: tumor subtypes as distinct disease entities. Eur J Cancer 40: 2667-2675.
11. Segal E, Friedman N, Koller D, Regev A (2004) A module map showing conditional activity of expression modules in cancer. Nat Genet 36: 1090-1098.
12. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
13. Dozmorov MG, Hurst RE, Culkin DJ, Kropp BP, Frank MB, et al. (2009) Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells. Prostate 69: 1077-1090.
14. Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, et al. (2008) Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Lett 259: 28-38.
15. Ergün A, Lawrence CA, Kohanski MA, Brennan TA, Collins JJ (2007) A network biology approach to prostate cancer. Mol Syst Biol 3: 82.
16. Ngan S, Stronach EA, Photiou A, Waxman J, Ali S, et al. (2009) Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene 28: 2051-63.
17. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, et al. (2007) Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7: 64.
18. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A (2003) Global analysis of protein expression in yeast. Nature 425: 737-741.
19. Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, et al. (2008) Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 9: 246.
20. de Godoy LMF, Olsen JV, Cox J, Nielsen ML, Hubner NC, et al. (2008) Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455: 1251-1254.
21. Waters KM, Pounds JG, Thrall BD (2006) Data merging for integrated microarray and proteomic analysis. Brief Funct Genomic Proteomic 5: 261-272.
22. Cox B, Kislinger T, Emili A (2005) Integrating gene and protein expression data: pattern analysis and profile mining. Methods 35: 303-314.
23. Greenbaum D, Jansen R, Gerstein M (2002) Analysis of mRNA expression and protein abundance data: an approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts. Bioinformatics 18: 585-596.
24. Dezso Z, Nikolsky Y, Nikolskaya T, Miller J, Cherba D, et al. (2009) Identifying disease-specific genes based on their topological significance in protein networks. BMC Syst Biol 3: 36.
25. Vellaichamy A, Sreekumar A, Strahler JR, Rajendiran T, Yu J, et al. (2009) Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases. PLoS One 4: e7075.
26. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, et al. (2000) Inhibition of integrin-linked kinase (ILK) suppresses activation of proteinkinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97: 32073212.
27. Réhault S, Monget P, Mazerbourg S, Tremblay R, Gutman N, et al. (2001) Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. Eur J Biochem 268: 2960-2968.
28. Okabe E, Kajihara J, Usami Y, Hirano K (1999) The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3. FEBS Lett 447: 87-90.
29. Sutkowski DM, Goode RL, Baniel J, Teater C, Cohen P, et al. (1999) Growth regulation of prostatic stromal cells by prostate-specific antigen. J Natl Cancer Inst 91: 1663-1669.
30. Maeda H, Yonou H, Yano K, Ishii G, Saito S, et al. (2009) Prostate-specific antigen enhances bioavailability of insulin-like growth factor by degrading insulin-like growth factor binding protein 5. Biochem Biophys Res Commun 381: 311-316.
31. Kim J, Jia L, Stallcup MR, Coetzee GA (2005) The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptormediated transcription at the prostate-specific antigen locus. J Mol Endocrinol 34: 107-118.
32. Irizarry R, Hobbs B, Collin F, Beazer-Barclay Y, Antonellis K (2003) Speed exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostat 4: 149-264.
33. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, et al. (2009) A novel signaling pathway impact analysis. Bioinformatics 25: 75-82.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
35. Sartor MA, Leikauf GD, Medvedovic M (2009) LRpath: a logistic regression approach for identifying enriched biological groups in gene expression data. Bioinformatics 25: 211-217.